NCT Number: NCT04106973
Estimated Enrollment: 300
Phases:
Age Group: 18 Years and older   (Adult, Older Adult)
Gender: All
Study Type: Observational
Study Results: No Results Available

Study Design Allocation: Allocation: No Results Available

Study ID Numbers: 1432436
Study First Received: September 27, 2019
Last Updated: July 20, 2021
Estimated Primary Completion Date: July 2022
Completion Date: July 2023

Primary Outcome Measures: VOC markers in breath samples. Predictive capability, sensitivity and specificity of biomarkers present in volatile organic compounds (VOC) for the early detection of pleural Mesothelioma in patients exposed to asbestos.|Predictive capability, sensitivity and specificity of Soluble Mesothelin Related Peptides (SMRP) in serum when combined with VOC biomarkers for pleural mesothelioma.

Sponsors and Collaborators: Ascension South East Michigan|International Association of Heat and Frost Insulators and Allied Workers|Owlstone Ltd|Fujirebio Diagnostics, Inc.
Funded By: Other|Industry
Interventions: Drug:

Locations: Consultants in Sleep and Pulmonary Medicine, Farmington Hills, Michigan, United States

Website Link: https://ClinicalTrials.gov/show/NCT04106973